99
Participants
Start Date
September 30, 2001
Primary Completion Date
April 30, 2004
Study Completion Date
April 30, 2004
Ethyl-eicosapentaenoic acid (EPA)
Capsules, 2 g per day for 16 weeks
Vitamins E + C
RRR-alpha-tocopherol 392 mg + slow-release ascorbic acid 1000 mg per day, for 16 weeks
Etyl EPA (placebo)
Paraffin oil. Capsules, each 0.5 g.
Vitamins E+C (placebo)
Tablets containing dicalciumphosphate
Aker University Hospital, Oslo
Collaborators (1)
Diakonhjemmet Hospital
OTHER
Stanley Medical Research Institute
OTHER
Laxdale Ltd
UNKNOWN
Scandinavian Society for Psychopharmacology
UNKNOWN
Shipowner Emil Stray's legacy
UNKNOWN
Johanne and Einar Eilertsen's research fund
UNKNOWN
AstraZeneca
INDUSTRY
Solveig and Johan P. Sommer's foundation
UNKNOWN
Josef and Haldis Andresen's legacy
UNKNOWN
University of Oslo
OTHER
Norwegian University of Science and Technology
OTHER
University Hospital, Aker
OTHER